Partial P2Y12 receptor blockade by clopidogrel may not be overcome by increasing the clopidogrel dose

被引：0
|
作者：
Judge, H. [1 ]
Buckland, R. [1 ]
Crosdale, D. [1 ]
Storey, R. F. [1 ]
机构：
[1] Univ Sheffield, CVRU, Sheffield, S Yorkshire, England
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [21] Blockade of the P2Y12 signaling Pathway with Clopidogrel Restrains Treg Proliferation In Vivo during Sepsis and in Vitro
    Vemulapalli, Harika
    Samara, Albayati
    Tsygankov, Alexander Y.
    Liverani, Elisabetta
    BLOOD, 2018, 132
  • [22] CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY
    Ueno, Masafumi
    Ferreiro, Jose Luis
    Dharmashankar, Kodlipet
    Capranzano, Piera
    Capodanno, Davide
    Darlington, Andrew
    Bhaloo, Desai
    Charlton, Ronald
    Box, Lyndon
    Zenni, Martin
    Guzman, Luis
    Bass, Theodore
    Angiolillo, Dominick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [23] Reversible binding of cangrelor to the P2Y12 receptor prevents the binding of clopidogrel and prasugrel active metabolites
    Buckland, R. J.
    Judge, H. M.
    Sugidachi, A.
    Jakubowski, J. A.
    Storey, R. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 942 - 942
  • [24] The antiplatelet effect of ASP1645, a novel P2Y12 receptor antagonist, compared with clopidogrel
    Uemura, T.
    Kawasaki, T.
    Sakata, C.
    Shigenaga, T.
    Moritani, Y.
    Takasaki, J.
    Koga, Y.
    Ito, H.
    Mutoh, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 946 - 946
  • [25] P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients
    Jorgensen, Niklas R.
    Schwarz, Peter
    Iversen, Helle K.
    Vestergaard, Peter
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [26] Clopidogrel and Neuraxial Block The Role of the PFA II and P2Y12 Assays
    Benzon, Honorio T.
    Fragen, Robert
    Benzon, Hubert A.
    Savage, Jason
    Robinson, Jennifer
    Puri, Lalit
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2010, 35 (01) : 115 - 115
  • [27] P2Y12 Receptor Blockade and Myocardial Perfusion
    Gurbel, Paul A.
    Tantry, Udaya S.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (07) : 684 - 686
  • [28] Detection of clopidogrel resistance: comparison of a new, P2Y12 receptor specific platelet aggregation test and other laboratory methods in patients on clopidogrel monotherapy
    Bagoly, Z.
    Sarkady, F.
    Magyar, T.
    Pongracz, E.
    Kappelmayer, J.
    Csiba, L.
    Muszbek, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 48 - 48
  • [29] Antiplatelet Therapy n ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors
    Ristorto, Jessica
    Messas, Nathan
    Marchandot, Benjamin
    Kibler, Marion
    Hess, Sebastien
    Meyer, Nicolas
    Schaeffer, Michael
    Tuzin, Nicolas
    Ohlmann, Patrick
    Jesel, Laurence
    Morel, Olivier
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 674 - 689
  • [30] Relation between the P2Y12 receptor gene variant and response to clopidogrel in patients with acute coronary syndromes
    Malek, L. A.
    Kisiel, B.
    Spiewak, M.
    Filipiak, K. J.
    Glowczynska, R.
    Grabowski, M.
    Ploski, R.
    Opolski, G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 758 - 758
12345